Literature DB >> 23442942

Is a minimally invasive approach for resection of benign cardiac masses superior to standard full sternotomy?

Andrés M Pineda1, Orlando Santana, Mery Cortes-Bergoderi, Joseph Lamelas.   

Abstract

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'is a minimally invasive approach for resection of benign cardiac masses superior to standard full sternotomy?' A total of 50 papers were found using the reported search, of which, 11 represented the best evidence to answer the clinical question. The authors, country, journal, date of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. All 11 papers were retrospective studies, from which 4 were case-control studies comparing the minimally invasive approach with conventional full sternotomy, and 7 were case series. There were two minimally invasive techniques used, a right mini-thoracotomy and a partial hemi-sternotomy, the former being the most commonly used. The resection of benign cardiac masses is a low-risk procedure, with no mortality or conversions to full sternotomy reported. From the 4 case-control studies, cross-clamp time was similar in both groups, and only one report found a prolonged perfusion time with the minimally invasive approach. The incidence of major postoperative complications, including bleeding requiring reoperation (average from case-control studies: 0-4.5 vs 0-5.8%), renal failure (0 vs 0-10%) and prolonged ventilation (6-13 vs 11-19%), for the two approaches was similar. The incidence of postoperative stroke was better for the minimally invasive approach in one study (0 vs 14%, P = 0.023). The main advantages of this technique are shorter intensive care unit (26-31 vs 46-60 h) and hospital stay (3.6-5.2 vs 6.2-7.4 days), the minimally invasive approach being significantly better in one and three reports, respectively. We conclude that minimally invasive resection of a benign cardiac mass using a right mini-thoracotomy approach can be performed with an operative morbidity and mortality at least similar to the standard full sternotomy approach. The information currently available for the minimally invasive approach for the resection of benign cardiac masses is limited and based only on retrospective studies and, therefore, prospective studies are required to confirm the potential benefits of minimally invasive surgery.

Entities:  

Keywords:  Cardiac masses; Cardiac tumours; Minimally invasive cardiac surgery; Review; Sternotomy

Mesh:

Year:  2013        PMID: 23442942      PMCID: PMC3653477          DOI: 10.1093/icvts/ivt063

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  12 in total

1.  Robotic excision of atrial myxoma.

Authors:  Jonathan Schilling; Amy M Engel; Mohammed Hassan; J Michael Smith
Journal:  J Card Surg       Date:  2012-05-29       Impact factor: 1.620

2.  Surgical experience with 77 primary cardiac tumors.

Authors:  Torsten Bossert; Jan F Gummert; Roberto Battellini; Markus Richter; Markus Barten; Thomas Walther; Volkmar Falk; Friedrich Wilhelm Mohr
Journal:  Interact Cardiovasc Thorac Surg       Date:  2005-04-18

3.  Minimally invasive aortic valve papillary fibroelastoma resection.

Authors:  Vivian M Hsu; Pavan Atluri; Martin G Keane; Y Joseph Woo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2006-08-30

4.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

5.  Minimally invasive surgery for cardiac myxomas using an upper hemi-sternotomy and biatrial septal approach.

Authors:  Indra A J Nordstrand; Robert K W Tam
Journal:  Heart Lung Circ       Date:  2005-07-20       Impact factor: 2.975

6.  Outcomes of a minimally invasive approach compared with median sternotomy for the excision of benign cardiac masses.

Authors:  Andrés M Pineda; Orlando Santana; Carlos Zamora; Alexandre M Benjo; Gervasio A Lamas; Joseph Lamelas
Journal:  Ann Thorac Surg       Date:  2011-03-21       Impact factor: 4.330

7.  Long-term outcomes with a minimally invasive approach for resection of cardiac masses.

Authors:  Alexander Iribarne; Rachel Easterwood; Mark J Russo; Jonathan Yang; Faisal H Cheema; Craig R Smith; Michael Argenziano
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

8.  Minimally invasive versus standard approach for excision of atrial masses.

Authors:  Mark J Russo; Timothy P Martens; Kimberly N Hong; David L Colman; Vinod B Voleti; Craig R Smith; Michael Argenziano
Journal:  Heart Surg Forum       Date:  2007       Impact factor: 0.676

9.  Video-assisted minimal access in excision of left atrial myxoma.

Authors:  P J Ko; C H Chang; P J Lin; J J Chu; F C Tsai; C Hsueh; M W Yang
Journal:  Ann Thorac Surg       Date:  1998-10       Impact factor: 4.330

10.  Minimally invasive video-assisted approach for left atrial myxoma resection.

Authors:  Nicola Vistarini; Alessia Alloni; Marco Aiello; Mario Viganò
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-10-27
View more
  3 in total

1.  Outcomes of video-assisted minimally invasive approach through right mini-thoracotomy for resection of benign cardiac masses; compared with median sternotomy.

Authors:  Sadanari Sawaki; Toshiaki Ito; Atsuo Maekawa; Satoshi Hoshino; Yasunari Hayashi; Junji Yanagisawa; Masayosi Tokoro; Takahiro Ozeki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-08-02

2.  An asymptomatic right atrial intramyocardial lipoma: a management dilemma.

Authors:  Haiyong Wang; Jiangwei Hu; Xiaolin Sun; Pingshan Wang; Zhenzong Du
Journal:  World J Surg Oncol       Date:  2015-02-06       Impact factor: 2.754

3.  The First Manifestation of a Left Atrial Myxoma as a Consequence of Multiple Left Coronary Artery Embolisms.

Authors:  Martin Novak; Petr Fila; Ota Hlinomaz; Vita Zampachova
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.